Home > Boards > US Listed > Biotechs > AEterna Zentaris Inc. (AEZS)

We are now at day 263 of the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Investwisely123 Member Profile
 
Followed By 1
Posts 39
Boards Moderated 0
Alias Born 11/16/18
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/10/2019 4:01:58 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/6/2019 2:32:15 PM
Aeterna Zentaris Provides Corporate Update GlobeNewswire Inc. - 6/6/2019 2:06:40 PM
Amended Securities Registration (section 12(b)) (8-a12b/a) Edgar (US Regulatory) - 5/9/2019 4:32:19 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/9/2019 4:10:06 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/9/2019 6:08:45 AM
Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting GlobeNewswire Inc. - 5/8/2019 6:04:22 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/7/2019 5:23:29 PM
Aeterna Zentaris Reports First Quarter 2019 Financial and Operating Results GlobeNewswire Inc. - 5/7/2019 5:12:12 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/7/2019 4:40:07 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/1/2019 6:24:31 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 4/1/2019 6:03:58 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/27/2019 2:04:26 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/26/2019 5:28:03 PM
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results GlobeNewswire Inc. - 3/26/2019 5:22:03 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/22/2019 4:43:08 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/19/2019 8:02:18 AM
Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019 GlobeNewswire Inc. - 3/19/2019 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 3/18/2019 6:09:40 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/12/2019 4:51:23 PM
Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor GlobeNewswire Inc. - 3/12/2019 4:32:37 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/22/2019 1:18:07 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/11/2019 3:28:01 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/11/2019 1:42:02 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/16/2019 9:09:31 AM
Investwisely123   Monday, 01/07/19 12:36:05 PM
Re: None
Post # of 16213 
We are now at day 263 of the European drug approval process. Standing committee consultation should have finished their consultation by January 5th according to EMA guidelines. The ball is now in the European Commisions court now and they have deadline of January 21 (day 277) to report their final decision of Macrilen drug approval in Europe. Thus, Macrilen could conceivably be approved in Europe any day now up until the deadline of January 21st! https://www.ema.europa.eu/documents/presentation/marketing-authorisation-evaluation-process-dr-evdokia-korakianiti_en.pdf

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist